
Home Chapter Home Jobs Conferences Fellowships Books
Breast-malignant, males, children
Glycogen rich (clear cell) carcinoma
Author: Nat Pernick, M.D, PathologyOutlines.com, Inc.
Reviewer: Daniel Visscher, M.D., University of Michigan Hospitals, February 2009 (see Reviewers page)
Revised: 26 September 2009
Last major update: September 2009
Copyright: (c) 2002-2009, PathologyOutlines.com, Inc.
Definition
=========================================================================
● Breast carcinoma in which at least 90% of the neoplastic cells have abundant clear cytoplasm due to glycogen
● First described in 1981 (Cancer 1981;48:2003)
● Rare; 1-3% of breast carcinomas
● May be a variant of apocrine carcinoma
Treatment and prognosis
=========================================================================
● Prognosis similar to invasive ductal carcinoma (AJSP 1995;19:904)
Xray images
=========================================================================
Mammogram shows circumscribed mass
Case reports
=========================================================================
● 33 year old woman whose tumor had neuroendocrine features (Pathologica 2001;93:676)
● 45 year old woman with solid papillary tumor (J Clin Pathol 2003;56:552)
● 59 year old woman (World J Surg Oncol 2008;6:44)
● 61 year old woman (Archives 2003;127:1629)
Gross images
=========================================================================
Solid papillary pattern within cystically dilated duct (Fig 1A)
Microscopic description
=========================================================================
● Solid or solid / papillary patterns of large clear cells with distinct cell borders containing glycogen in 90% or more cells
● Often associated with intraductal component of varied type
● Often has apocrine features
● Cells have clear to granular cytoplasm
● May have scant intracellular mucin (Histopathology 1987;11:857)
● No cytoplasmic vacuoles
Micro images
=========================================================================
Tumor cells with distinct borders Resembles renal clear cell carcinoma
and clear cytoplasm
Tumor cells contain abundant cytoplasmic glycogen
Fig 1/2: Infiltrating nests of atypical cells with Polygonal cells with distinct cell borders,
abundant clear cytoplasm clear cytoplasm and prominent nucleoli (Fig 1B/1C)
Fig 3: PAS+ granules
Fig 4: PAS staining is removed by diastase
CK8/18+
AFIP images
Sheets of polygonal cells with distinct borders, Clear cells surround a small group of
clear cytoplasm and small nuclei, also tumor cells with amphophilic cytoplasm
lymphocytes and plasma cells (arrows)
PAS+ dark granules are due to glycogen, and are abolished by diastase
Cytology description
=========================================================================
● Hypercellular with tumor cells in loosely cohesive syncytial groups and some single cells
● Most tumor cells have abundant, finely granular eosinophilic cytoplasm or foamy to clear cytoplasm with well defined cytoplasmic membranes and moderate/marked nuclear pleomorphism with central round/oval nuclei containing prominent nucleoli (Acta Cytol 2008;52:65)
● PAS staining may be helpful (J Med Invest 2002;49:193)
Positive stains
=========================================================================
● PAS-diastase sensitive (glycogen)
Negative stains
=========================================================================
● CK20, lipid stains (done on fresh/frozen tissue)
Electron microscopy
=========================================================================
● Non-membrane bound glycogen and empty glycogen lakes
● Tight junctions between tumor cells, immature desmosomes, occasional short microvilli (AJSP 1986;10:553)
Differential diagnosis
=========================================================================
● Clear cell “sugar” tumor - positive for melanocytic markers (AJSP 2002;26:670)
● Lipid-rich carcinoma
● Apocrine carcinoma
● Secretory carcinoma - younger patients, low grade histology
● Myoepithelial lesions
Additional references
=========================================================================
● Hum Path 1991;22:81, Stanford University
End of Breast – Malignant, Males, Children > Glycogen rich (clear cell) carcinoma
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must also be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by Copyright, (c) 2001-2009, PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions.